Project Grant R01AI189930
Award Date
6/20/25
Completion Date
5/31/30
Dollars Obligated
$593K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $668,488.00 to The Washington University in St. Louis over a 5-year period starting February 1, 2025. The funding supports research to investigate the mechanisms by which the rotavirus outer capsid protein VP4 interacts with the host cell's actin-related protein 2/3 (Arp2/3) complex to enable cell-to-cell...
This federal Project Grant award of $502,248.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Florida's Division of Sponsored Research. The grant aims to investigate how human intestinal epithelial cells produce type III interferons, specifically IFNL2/3, to protect against rotavirus infection. Key objectives include determining how the STING pathway senses...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $170,640 to The Washington University to conduct a 5-year research program titled "Building an Atlas of B Cell Mediated Protective Immunity to Alphaviruses." The goal is to study the basis by which cross-reactive B cells are induced to arthritogenic alphaviruses in mice, which may inform the...
This Cooperative Agreement award for $2,380,350 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research at Washington University to study the mechanisms of broadly protective immune responses against respiratory viruses, including SARS-CoV-2 and influenza. The two main goals are: (A) defining the mechanisms of germinal center persistence after vaccination and how that impacts long-lived...
This federal Project Grant award, totaling $711,555.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The overarching goal of this 5-year project, awarded on May 13, 2025 and running through April 30, 2030, is to contribute to the fundamental understanding of the spatiotemporal transmission dynamics and control of vaccine-preventable childhood infections. The project aims to develop...
This Project Grant award of $197,366 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research program supports research to understand the mechanisms by which the human immune system naturally restricts a specific subset of HIV known as X4-tropic virus. The 5-year research study, commencing on March 1, 2025, aims to characterize the molecular mechanisms that drive the restriction of X4-tropic viral replication in the...
This federal Project Grant award of $649,053 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University. The grant supports research to investigate the role of the Ly49 family of receptors on CD8 T cells and their function in regulating immune responses. Specifically, the research aims to understand how Ly49 and the transcription factor Helios contribute to the development...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $153,512 to The Washington University in St. Louis to conduct research on how bacteria's anti-viral defense system, known as the DARTG system, senses and responds to bacteriophage (viral) infection. The goal is to elucidate the mechanisms by which the DARG1 protein, which is part of the DARTG anti-viral system, can...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $226,253 to The Washington University in St. Louis to conduct research on modulating neutrophil-endothelial interactions by the ADAM10 protein in the context of Staphylococcus aureus infections. The goal is to generate a spatiotemporal analysis of the interaction between neutrophils and the endothelium during the early...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $456,000 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the University of Texas Medical Branch at Galveston (UTMB) to investigate how regulatory mechanisms shape the interleukin-6 (IL-6) immune response during respiratory viral infections. The two-year grant (July 2024 - June 2026) aims to understand how changes in a cis-regulatory element control IL-6 expression in mucosal epithelial cells,...